FDA Adverse Event Malfunction Summary report: N

INFUSOR

MDR report key: 3903122 · Received June 30, 2014

Report

Report Number
1416980-2014-20925
Event Type
Malfunction
Date Received
June 30, 2014
Date of Event
April 9, 2014
Report Date
April 9, 2014
Manufacturer
BAXTER HEALTHCARE - IRVINE
Product Code
MEB
PMA / PMN Number
K071222
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4).THE DEVICE WAS MANUFACTURED BETWEEN OCTOBER 16, 2013 ¿ OCTOBER 17, 2013. EVALUATION SUMMARY: THE DEVICE WAS RECEIVED FOR EVALUATION. VISUAL INSPECTION DID NOT IDENTIFY ANY ABNORMALITIES THAT COULD HAVE CONTRIBUTED TO THE REPORTED CONDITION. THE BACKFLOW FROM THE FILL PORT WAS NOTED DURING FUNCTIONAL LEAK TESTING. FURTHER EXAMINATION OF THE DEVICE REVEALED THAT THERE WAS A PARTICLE APPROXIMATELY 1 MM IN SIZE, TRAPPED UNDER THE CHECK BAND. FT-IR SPECTROPHOTOMETER SCANNING REVEALED THAT THE PARTICLE WAS MADE OF POLYPROPYLENE. THE BACKFLOW WAS DETERMINED TO BE DUE TO THE PARTICLE. A BATCH REVIEW WAS CONDUCTED AND THERE WERE NO DEVIATIONS FOUND RELATED TO THIS REPORTED CONDITION DURING THE MANUFACTURE OF THIS LOT. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Additional Manufacturer Narrative · 1

(B)(4). A CAPA HAS BEEN OPENED TO FURTHER INVESTIGATE THE PRESENCE OF PARTICULATE MATTER INSIDE THE FLUID PATHWAY. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

DURING EVALUATION OF A RETURNED LARGE VOLUME INFUSOR, BACKFLOW (LEAK) WAS NOTED FROM THE FILLING PORT OF THE DEVICE. THERE WAS NO PATIENT INVOLVEMENT AS THE CONDITION WAS IDENTIFIED DURING EVALUATION. NO ADDITIONAL INFORMATION IS AVAILABLE. THIS IS REPORT 2 OF 2.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
380329 INFUSOR PUMP, INFUSION, ELASTOMERIC MEB BAXTER HEALTHCARE - IRVINE 12K052

Patients

Seq Age Sex Outcome Treatment
1